_ray-kausik-ada-2017-pt-1-pcsk9-inhibitor-treatment-for-diabetes.jpg "Ray Kausik ADA 2017 Pt.1 PCSK9 Inhibitor Treatment For Diabetes from pcsk Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1 min 85 sec
✓ Published: 20-Aug-2017
✓ Published: 20-Aug-2017
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_isu-168-pcsk9-de.webp "ISU 168 PCSK9 DE from pcsk")
_professor-mark-caulfield-co-director-of-the-william-harvey-research-institute-talks-about-pcsk9-and-fourier.webp "Prof. Mark Caulfield talks about the FOURIER study in which patients at the William Harvey Clinical Research Centre have been involved. Some of their personal stories are also available on this site.nThis video was produced for the announcement of the results of the FOURIER study, funded by Amgen, in March 2017.nProduction for TrialsConnect was by Greenacre Communications – a London-based video production company specialising in health-care issues and started by John, a former patient involved")
⏲ 2 min 29 sec ✓ 19-Mar-2017
_ray-kausik-ada-2017-pt-7-pcsk9-inhibitor-side-effects.webp "Ray Kausik ADA 2017 Pt.7 PCSK9 Inhibitor Side Effects from pcsk")
_isu-168-pcsk9-fr.webp "ISU 168 PCSK9 FR from pcsk")
_ray-kausik-ada-2017-pt-4-pcsk9-and-sglt2-combination-therapy.webp "Ray Kausik ADA 2017 Pt.4 PCSK9 And SGLT2 Combination Therapy from pcsk")
_lp-a-pcsk-9-fourier-and-more---scientific-update---november-2021-sd-mp4.webp "lp_a_pcsk-9_fourier_and_more_-_scientific_update_-_november_2021_SD.mp4 from pcsk")
⏲ 42 min 20 sec ✓ 13-Dec-2021
_2-pam-taub-pcsk9.webp "2 Pam Taub PCSK9 from pcsk")
_acc2016-pr-steven-nissen-cleveland-ohio.webp "Pr. Steven Nissen (Cleveland, Ohio) : « Les douleurs musculaires avec les statines sont un problème bien réel »nLe Pr. Steven Nissen a présenté les résultats de l’étude GAUSS-3 lors du congrès de l’American College of Cardiology. Ils démontrent d’une part que les symptômes douloureux musculaires observés avec les statines constituent bien un problème physique réel et confirment la supériorité des inhibiteurs des PCSK-9, comme l’evolocumab, pour normaliser les taux sériqu")
_isu-168-pcsk9-de.jpg)
_professor-mark-caulfield-co-director-of-the-william-harvey-research-institute-talks-about-pcsk9-and-fourier.jpg)
_ray-kausik-ada-2017-pt-7-pcsk9-inhibitor-side-effects.jpg)
_isu-168-pcsk9-fr.jpg)
_ray-kausik-ada-2017-pt-4-pcsk9-and-sglt2-combination-therapy.jpg)
_lp-a-pcsk-9-fourier-and-more---scientific-update---november-2021-sd-mp4.jpg)
_2-pam-taub-pcsk9.jpg)
_acc2016-pr-steven-nissen-cleveland-ohio.jpg)
![[+]](/images/menu.gif){kind=small}